Samantha Meltzer-Brody is an American physician who is the Assad Meymandi Distinguished Professor, Chair of Psychiatry, and Executive Dean at the UNC School of Medicine. She researches new strategies to support people with postnatal depression. She was elected Fellow of the National Academy of Medicine.
In 2004, Meltzer-Brody founded the UNC Perinatal Psychiatry Program.[3] She is a specialist in perinatal depression, which is experienced by one in eight people who give birth.[4] She studies the epidemiological predictors of perinatal depression.
Meltzer-Brody has led clinical trials to identify appropriate medication for postpartum depression, including brexanolone, zulresso and zuranolone.[4] Zulresso was the first drug specifically developed for postpartum depression.[5] Meltzer-Brody has explained that the “weeks and months following birth are a critical period for mother-infant bonding, so finding a fast-acting treatment is crucial for both mom and baby”.[3] Meltzer-Brody has investigated the epidemiology and biomarker models of peri and postnatal depression. She created the international PostpArtum depression ConsorTium, PACT, which encourages international efforts to identify perinatal mood disorders.[6]
In 2011, Meltzer-Brody founded the UNC “Taking Care of Our Own” program, which looked to eliminate physician burnout.[7] Physician burnout can impact professional behaviour, home relationships and patient outcomes.[7]
Meltzer-Brody was made Assad Meymandi Distinguished Professor and Chair of the Department of Psychiatry. She Directed the UNC Center for Women’s Mood Disorders, and worked closely with the state of North Carolina on mental health provision.[citation needed]
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.
